Price History
Feb 9, 2026 — May 11, 2026Investment Snapshot
- P/B of 7.64 — trading above book value
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -256.5%
- Revenue growing at 20% annually
MDxHealth SA - Ordinary Shares (MDXH) is a Healthcare company operating in Services-Medical Laboratories, listed on the NASDAQ , with a market capitalisation of $103 million . Key value metrics: P/B ratio 7.64, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
MDxHealth SA - Ordinary Shares — Fundamental Analysis Summary
On financial health, MDXH shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -256.5% (sector average: -20.6%), and high leverage with a debt-to-equity ratio of 2.40.
StockPik's composite Value Score for MDXH is 60/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
MDXH reports a high gross margin of 64.5% (sector average: 40.1%) and a negative operating margin of -13.4%.
MDXH shows revenue growing at 20% year-over-year, with earnings growing at 12%.